Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Shimizu H et al. - Intravenous immunoglobulin (400 mg/kg/d for 5 d) in a single cycle is an effective and safe treatment for patients with pemphigus who are relatively resistant to systemic steroids. Time to escape from the protocol is a useful indicator for evaluation in randomized, placebo-controlled, double-blind studies of rare and serious diseases.

Related Articles

Pemphigus vegetans in a patient with colonic cancer
Indian Journal of Dermatology, Venereology and Leprology, 11/20/09    Relevance Score: 91%

Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris
Journal of the European Academy of Dermatology and Venereology, 12/02/09    Relevance Score: 88%

Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype
Clinical and Experimental Dermatology, 11/10/09    Relevance Score: 85%

Corticosteroid/cyclophosphamide pulse treatment in South African patients with pemphigus
Clinical and Experimental Dermatology, 11/16/09    Relevance Score: 82%

Today in Autoimmune/Bullous Dz...keeping you current

Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behcet's disease?
Journal of the European Academy of Dermatology and Venereology, 12/04/09

Hyper IgE syndrome with umbilical hernia
Indian Journal of Dermatology, 11/25/09

Pemphigus vegetans in a patient with colonic cancer
Indian Journal of Dermatology, Venereology and Leprology , 11/19/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address